Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 66 clinical trials
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans

This trial studies how well a lifestyle intervention works in reducing prostate cancer disparities among African American prostate cancer patients and their spouses or romantic partners. A lifestyle intervention may help researchers learn if social support can help African American prostate cancer patients and their partners improve their quality of …

exercise intervention
stage i prostate cancer ajcc v8
stage prostate cancer
stage iic prostate cancer ajcc v8
dementia
  • 0 views
  • 16 Feb, 2024
  • 1 location
Study of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer

Evaluate the safety and tolerability of AMG 509 in adult subjects and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).

blood transfusion
metastasis
dexamethasone
prostate specific antigen
testosterone
  • 0 views
  • 16 Feb, 2024
  • 4 locations
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer

The main purpose of this phase II trial study is to determine whether a positron emission tomography (PET)/computed tomography (CT) scan using 18F-DCFPyL affects the clinical management plan in Veterans. In this study, the management plan prior to and after 18F-DCFPyL PET/CT will be recorded by specific questionnaires and corresponding …

salvage therapy
external beam radiation therapy
conventional imaging
pet/ct scan
adenocarcinoma of prostate
  • 0 views
  • 05 Aug, 2020
EBRT and HDR Brachytherapy for Unfavorable-intermediate High and Very High-risk Prostate Cancer

This study is trying to find out if the combination of Androgen deprivation therapy (ADT), MRI guided high dose radiation (HDR) brachytherapy treatment (internal radiation implant procedure) and external beam radiation therapy (EBRT) treatments lead to less side effects. This study is also looking at patient outcomes, quality of life, …

external beam radiation therapy
androgens
androgen suppression
prostate adenocarcinoma
pelvic mri
  • 0 views
  • 16 Feb, 2024
  • 1 location
Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

In this research study, is assessing the feasibility of using an MR-guided implantable microdevice to measure tumor response to chemotherapy and other clinically relevant drugs in participants that have prostate cancer and are scheduled for a radical prostatectomy. The name of the study intervention involved in this study is: Implantation …

carcinoma
neutrophil count
prostatectomy
  • 2 views
  • 05 Aug, 2020
Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

This is a prospective, open-label, randomized, controlled, cross-over trial assessing patient preference for apalutamide versus enzalutamide in 146 male patients with recurrent or metastatic hormone-sensitive prostate cancer. The primary objective is to investigate whether there is any difference in patient preference between apalutamide and enzalutamide in patients with recurrent or …

androgens
apalutamide
androgen suppression
cancer
adenocarcinoma of prostate
  • 0 views
  • 16 Feb, 2024
  • 1 location
Diffusion Basis Spectrum Imaging of the Prostate

Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.

prostate cancer screening
biopsy of prostate
  • 0 views
  • 16 Feb, 2024
  • 1 location
HDR Brachytherapy 68-Ga-RM2 PET 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

This study is being conducted to determine whether the combination of imaging agents 68-Ga RM2 and 68-Ga PMSA11 is better at assessing response to high dose rate (HDR) local therapy than standard imaging or biopsy in patients with known prostate cancer (PC)

pet/mri
brachytherapy
local therapy
  • 0 views
  • 16 Feb, 2024
  • 1 location
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.

metastasis
castration-resistant prostate cancer
metastatic cancer
cancer
metastatic hormone refractory prostate cancer
  • 0 views
  • 16 Feb, 2024
  • 3 locations
MRI-guided Focal Laser Ablation

Magnetic resonance imaging-guided focal laser ablation of prostate cancer.

MRI
laser ablation
prostate specific antigen
transrectal ultrasound
diffusion weighted imaging
  • 0 views
  • 16 Feb, 2024
  • 1 location